-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: biotechnology
Bayh-Dole Podcast moderated by BIO with AUTM and patient advocate
Lila Feisee, Vice President for Global Intellectual Property Policy at BIO, moderated a podcast on the benefits of the Bayh-Dole Act and the need to maintain flexibility in our nation’s technology transfer system. She was joined by: Dr. Ashley Stevens, Special Assistant to the Vice President for Research Technology Development and Senior Research Associate at the Institute for Technology Entrepreneurship & Commercialization at the Boston University School of Management. He also serves as President of Read More >
AUTM’s 2010 Better World Report Highlights
AUTM released their Better World Report for 2010 highlighting academic innovations commercially developed through technology transfer that are improving the quality of life. Here is a quote from their press release. A device that allows the blind to ―see‖ via electrical pulses applied to the tongue…a collagen scaffold to treat damaged joints…a new vaccine to prevent shingles…an artificial lung that provides patients with both mobility and comfort during treatment…a program that vastly improves literacy among Read More >
Patently BIOtech
Leave a comment
Email This Post
Tags: Association of Technology Transfer Managers, AUTM, Bayh-Dole, BIO, biotechnology, economic development, federally funded research, Global Health, government funded research, healthcare, Licensing technology, modern medicine, new drug development, NIH, patents, Research and Development, Senator Birch Bayh, Senator Dole
Tags: Association of Technology Transfer Managers, AUTM, Bayh-Dole, BIO, biotechnology, economic development, federally funded research, Global Health, government funded research, healthcare, Licensing technology, modern medicine, new drug development, NIH, patents, Research and Development, Senator Birch Bayh, Senator Dole
Representative Conyers speech at AUTM’s 30th Anniversary Bayh-Dole event
Statement of the Honorable John Conyers, Jr. appearing at the Association of University Technology Managers 30th Anniversary of the Bayh-Dole Act Wednesday, December 1, 2010, at 10:00 a.m. Washington Convention Center I would like to thank you for inviting me to speak before this distinguished group of professionals today. America has always been a nation of dreamers and innovators. Edison’s lightbulb illuminated the world and the Wright brothers showed us that we could fly. We Read More >
BIO’s Comments on proposed PTO Humanitarian Technologies and Licensing Through the Intellectual Property System
Here are the highlights from BIO’s recent submission on the proposed PTO “Request for Comments on Incentivizing Humanitarian Technologies and Licensing Through the Intellectual Property System.” Background: 1. “BIO’s members also understand that problems with access to medicines and other biotechnology products in the developing world have very little to do with the patent system, and are generally caused by other factors outside the control of individual stakeholders, such as lack of adequate local manufacturing, Read More >
Patently BIOtech
1 Comment
Email This Post
Tags: access to medicines, BIO, BIOTECH, biotechnology, Biotechnology Industry Organization, developing countries, economic development, Global Health, Green Technology, humanitarian, humanitarian technologies, International, Patent and Trademark Office, Patent Reform, patents, poverty, PTO, re-examination vouchers, U.S. Patent and Trademark Office, United States Patent and Trademark Office, USPTO
Tags: access to medicines, BIO, BIOTECH, biotechnology, Biotechnology Industry Organization, developing countries, economic development, Global Health, Green Technology, humanitarian, humanitarian technologies, International, Patent and Trademark Office, Patent Reform, patents, poverty, PTO, re-examination vouchers, U.S. Patent and Trademark Office, United States Patent and Trademark Office, USPTO
BIO’s take on the CBD Nagoya Protocol
After several years of negotiations, the 10th Conference of the Parties of the Convention on Biological Diversity (CBD) successfully adopted the Nagoya Protocol. The Protocol provides benefits to the biotechnology industry by creating a legal framework to regulate access to genetic resources and provide fair and equitable sharing of benefits. In addition, the Protocol does not apply retroactively or hinder regulation or a country’s intellectual property systems. Assuming nations implement the Protocol appropriately, we can Read More >
